Comments
Cadila Pharmaceuticals Ltd has announced an agreement with Norway-based Inven2's start-up, Serca Pharmaceuticals, to develop a new treatments for heart patients.
The new drug is based on an invention by Professor Kjetil Taskén and co-workers at the University of Oslo and the Oslo University Hospital, an official statement said.
Serca's drug is aiming to help patients from developing secondary damage from cardiac disease, which is an unmet medical need. SERCA Pharmaceuticals will develop a drug treatment for injuries that occur when treating myocardial infarction, the statement said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.